The use of intrauterine devices (IUDs), including the copper‐bearing device and the
levonorgestrel intrauterine system (LNG‐IUS), is safe among nulligravidas and adolescent …

In 2015, a global learning agenda for the hormonal intrauterine device (IUD) was developed
with priority research questions regarding use of the method in low-and middle-income …

Few longitudinal studies have measured contraceptive continuation past one year in sub‐
Saharan Africa. We surveyed 674 women who had been randomized to receive the three …

Summary Background Globally, approximately 19.4% of women of reproductive age use
intrauterine contraception, encompassing both copper intrauterine devices (Cu-IUDs) and …

Medical technologies present a huge potential in improving global health playing a key role
toward achieving Sustainable Development Goal 3 by 2030. A number of clinicians …

Background: Women represent one quarter of the population living with HIV in Canada and
are an increasingly important sector of the HIV community. While some women's health …

Background People living with HIV have higher unmet family planning needs compared to
those without HIV. This is heightened for young people. However, the provision of family …

People capable of pregnancy are disproportionately affected by HIV. Family planning needs
and services are often unmet in this population, and clinical care guidelines regarding …

Background The levonorgestrel-releasing intrauterine device (IUD)—also known as the
hormonal IUD—is a highly effective contraceptive method that has not been widely available …

Objective To summarize and update information regarding drug-drug interactions (DDIs)
between antiretrovirals (ARVs) and hormonal contraceptives (HCs). Design Systematic …